Article Details

Legend Biotech (NASDAQ:LEGN) Upgraded by Zacks Investment Research to “Hold”

Retrieved on: 2022-04-21 17:11:10

Tags for this article:

Click the tags to see associated articles and topics

Legend Biotech (NASDAQ:LEGN) Upgraded by Zacks Investment Research to “Hold”. View article details on hiswai:

Excerpt

Millennium Management LLC now owns 152,034 shares of the company's stock valued at $7,086,000 after purchasing an additional 1,327 shares during the ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up